Top

Obesity Surgery

Published in:

01-03-2012 | Clinical Research

Is Laparoscopic Duodenojejunal Bypass with Sleeve an Effective Alternative to Roux En Y Gastric Bypass in Morbidly Obese Patients: Preliminary Results of a Randomized Trial

Authors: P. Praveen Raj, R. Kumaravel, C. Chandramaliteeswaran, S. Rajpandian, C. Palanivelu

Published in: Obesity Surgery | Issue 3/2012

Abstract

Background

The incidence of obesity and related metabolic disorders in India and that of stomach carcinoma is one of the highest in the world. Hence, one requires a procedure that allows postoperative surveillance of the stomach with the best outcomes in terms of weight control and resolution of co-morbidities. Here, we compare one such procedure, duodenojejunal bypass with sleeve against the standard Roux-en Y gastric bypass.

Methods

Fifty-seven patients who were selected for a bypass procedure were randomized into two groups of laparoscopic duodenojejunal bypass with sleeve (DJB) and laparoscopic Roux en Y gastric bypass. The limb lengths were similar in both the groups, and the sleeve was done over a 36F bougie.

Results

The mean body mass index and percent excess weight loss at the end of 3, 6, and 12 months between the groups were not statistically significant. The operating times were higher in the DJB group. The rate of resolution of diabetes, hypertension, and dyslipidemias were also similar with no statistical significance. There was 100% resolution of dyslipidemias in both groups. There was one patient in the DJB group who presented with internal herniation 1 month post-op and was managed surgically. There was no mortality in both the groups.

Conclusion

Laparoscopic duodenojejunal with sleeve gastrectomy, a procedure which combines the principles and advantages of sleeve gastrectomy and foregut hypothesis, is a safe and effective alternative to gastric bypass in weight reduction and resolution of co-morbidities especially for Asian countries. But, long-term follow-up is required.

US Census Bureau. International database. 2004.

WHO. Prevalence of diabetes in the world. 2003.

Beckman LM, Beckman TR, Earthman CP. Changes in gastrointestinal hormones and leptin after Roux en Y gastric bypass procedure: a review. Am Diet Assoc. 2010;110(4):571–84.CrossRef

Pories WJ, Albrecht RJ. Etiology of type II diabetes mellitus: role of the foregut. World J Surg. 2001;25:527–31.PubMedCrossRef

Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals the role of proximal small intestines in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741–9.PubMedCrossRef

Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux en Y-500 patients: technique and results, with 3–60 month follow up. Obes Surg. 2000;10(3):233–9.PubMedCrossRef

Higa KD, Boone KB, Ho T. Complications of the laparoscopic Roux en Y gastric bypass: 1040 patients—what have we learned? Obes Surg. 2000;10(6):509–13.PubMedCrossRef

Higa KD, Ho T, Boone KB. Laparoscopic Roux en Y gastric bypass: technique and 3-year follow up. J Laparoendosc Adv Surg Tech A. 2001;11(6):377–82.PubMedCrossRef

Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux en Y gastric bypass for morbid obesity. Ann Surg. 2000;232(4):515–29.PubMedCrossRef

10.

Tagaya N, Kasama K, Inamine S, et al. Evaluation of the excluded stomach by double-balloon endoscopy after laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2007;17:1165–70.PubMedCrossRef

11.

National Cancer Registry Programme (India). Consolidated report of hospital based cancer registries 2001–2003.

12.

Swaminathan R, Selvakumaran R, Esmy PO, et al. Cancer pattern and survival in a rural district in South India. Cancer Epidemiol. 2009;33(5):325–31.PubMedCrossRef

13.

Sambasivaiah K, Ibrarullah M, Reddy MK, et al. Clinical profile of carcinoma stomach at a tertiary care hospital in South India. Trop Gastroenterol. 2004;25(1):21–6.PubMed

14.

O’Connor EA, Carlin AM. Lack of correlation between small volume gastric pouch size and weight loss after laparoscopic Roux en Y gastric bypass. SOARD 2008;399–403.

15.

Kinra S, Bowen LJ, Lyngdoh T, et al. Sociodemographic patterning of non-communicable disease risk factors in rural India: a cross sectional study. BMJ. 2010;341:4974.CrossRef

16.

Praveen Raj P, Chandramaliteeswaran C, Senthilnathan P, et al. Bariatric to metabolic surgery: management options and experience at a tertiary centre. J Indian Med Assoc. 2010;108:645–7.PubMed

17.

Lee WJ, Wang W. Bariatric surgery: Asia-Pacific perspective. Obes Surg. 2005;15:751–7.PubMedCrossRef

18.

Stefanidis D, Kuwada TS, Gersin KS. The importance of the limb length of the limbs for gastric bypass patients—an evidence-based review. Obes Surg. 2011;21(1):119–24.PubMedCrossRef

19.

Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.PubMedCrossRef

20.

Pories W, Swanson M, Macdonald K, et al. Who would have thought it? An effective operation proves to be the most effective therapy for adult onset diabetes mellitus. Ann Surg. 1995;222:339–52.PubMedCrossRef

21.

Rubino F, Zizzari P, Tomasetto C, et al. The role of the small bowel in the regulation of circulating Ghrelin levels and food intake in the obese Zucker rat. Endocrinology. 2005;146:1745–51.PubMedCrossRef

22.

Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239:1–11.PubMedCrossRef

23.

Pacheco D, de Luis DA, Romero A, et al. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto–Kakizaki rats. Am J Surg. 2007;194:221–4.PubMedCrossRef

24.

Wang TT, Hu SY, Gao HD, et al. Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg. 2008;247:968–75.PubMedCrossRef

25.

Lakdawala MA, Bhasker A, Mulchandani D, et al. Comparison between the results of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass in the Indian population: a retrospective 1 year study. Obes Surg. 2010;20(1):1–6. Epub 2009 Oct 3.PubMedCrossRef

26.

Shah SS, Todkar JS, Shah PS, et al. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m(2). Surg Obes Relat Dis. 2010;6(4):332–8. Epub 2009 Sep 3.PubMedCrossRef

27.

Csendes A, Burdiles P, Papapietro K, et al. Results of gastric bypass plus resection of the distal excluded gastric segment in patients with morbid obesity. J Gastrointest Surg. 2005;9(1):121–31.PubMedCrossRef

28.

Khitin L, Roses RE, Birkett DH. Cancer in the gastric remnant after gastric bypass; a case report. Curr Surg. 2003;60(5):521–3.PubMedCrossRef

29.

Escalona A, Guzman S, Ibanez L, et al. Gastric cancer after Roux-en-Y gastric bypass. Obes Surg. 2005;15(3):423–7.PubMedCrossRef

30.

Padoin AV, Galvao Neto M, Moretto M, et al. Obese patients with type 2 diabetes submitted to banded gastric bypass: greater incidence of dumping syndrome. Obes Surg. 2009;19:1481–4.PubMedCrossRef

31.

Loss AB, de Souza AA, Pitombo CA, et al. Analysis of the dumping syndrome on morbid obese patients submitted to Roux en Y gastric bypass. Rev Col Bras Cir. 2009;36(5):413–9.PubMedCrossRef

32.

Kasama K, Tagaya N, Kanehira E, et al. Laparoscopic sleeve gastrectomy with duodenojejunal bypass: technique and preliminary results. Obes Surg. 2009;19:1341–5.PubMedCrossRef

33.

Navarrete SA, Leyba JL, Llopis SN. Laparoscopic sleeve gastrectomy with duodenojejunal bypass for the treatment of type 2 diabetes in non-obese patients: technique and preliminary results. Obes Surg. 2011;21(5):663–7.PubMedCrossRef

Title: Is Laparoscopic Duodenojejunal Bypass with Sleeve an Effective Alternative to Roux En Y Gastric Bypass in Morbidly Obese Patients: Preliminary Results of a Randomized Trial
Authors: P. Praveen Raj
R. Kumaravel
C. Chandramaliteeswaran
S. Rajpandian
C. Palanivelu
Publication date: 01-03-2012
Publisher: Springer-Verlag
Published in: Obesity Surgery / Issue 3/2012
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-011-0507-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Is Laparoscopic Duodenojejunal Bypass with Sleeve an Effective Alternative to Roux En Y Gastric Bypass in Morbidly Obese Patients: Preliminary Results of a Randomized Trial

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2012

The Effects of Chronically Increased Intra-abdominal Pressure on the Rabbit Diaphragm

Central Pedicled Breast Reduction Technique in Male Patients After Massive Weight Loss

Bariatric Surgery in Asia in the Last 5 Years (2005–2009)

Liver Upregulation of Genes Involved in Cortisol Production and Action Is Associated with Metabolic Syndrome in Morbidly Obese Patients

Efficacy of the Roux-en-Y Gastric Bypass Compared to Medically Managed Controls in Meeting the American Diabetes Association Composite End Point Goals for Management of Type 2 Diabetes Mellitus

Preoperative Transabdominal Ultrasonography (US) Prior to Laparoscopic Roux-en-Y Gastric Bypass (LRYGBP) and Laparoscopic Sleeve Gastrectomy (LSG) in the First 100 Operations. Was It Beneficial and Reliable During the Learning Curve?